Citations

Clear

5212 citation(s) found for "Wang, Li-Ju".

Dual Roles for the TSPYL Family in Mediating Serotonin Transport and the Metabolism of Selective Serotonin Reuptake Inhibitors in Patients with Major Depressive Disorder
Eugene, Andy R., Liu, Duan , Zhang, Lingxin , Neavin, Drew , Yu, Jia , Weinshilboum, Richard M. , Wang, Liewei , Neavin, Drew R , Liu, Duan , Qin, Sisi , Eugene, Andy R., Biernacka, Joanna M. , Weinshilboum, Richard M.

Mayo Clinic

Clinical Pharmacology & Therapeutics | October 19, 2019 | Volume: 107 | Issue: 3 | Pages: 662-670

10.1002/cpt.1692 | PMID 31628858 Get It

We previously reported that testis‐specific Y‐encoded‐like protein (TSPYLs) are transcription regulators for CYP3A4, CYP2C9, and CYP2C19. Here, we observed dual roles for TSPYLs in mediating serotonin transport and the metabolism of selective serotonin reuptake inhibitors (SSRIs) in patients with major depressive disorder (MDD). The widely prescribed SSRIs, citalopram, and escitalopram are metabolized mainly by CYP2C19. The TSPYL1 rs3828743 single nucleotide polymorphism (SNP), which decreases its suppression of CYP2C19 expression, was associated with rapid escitalopram metabolism and worse treatment response in the Mayo PGRN‐AMPS clinical trial. We also found that TSPYLs can regulate expression of the serotonin transporter protein, SLC6A4, and, in turn, serotonin transport into cells. The SNPs in tight linkage disequilibrium with the TSPYL1 rs10223646 SNP were significantly correlated with baseline severity of depression in patients with MDD in the Sequenced Treatment Alternatives to Relieve Depression and International SSRI Pharmacogenomics Consortium clinical trials. Our findings suggest that genetic variation in TSPYL genes may be novel indicators for baseline severity of depression and SSRI poor response.
Unique Phenotypic Characteristics and Clinical Course in Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis: A Multicenter US Experience
Wang, Ming‐Hsi , Mousa, Omar Y. , Friton, Jessica, Raffals, Laura E. , Leighton, Jonathan A. , Pasha, Shabana F., Picco, Michael F., Monroe, Kelly, Nix, Billy D., Newberry, Rodney D. , Faubion, William A. , Friton, Jessica J, Newberry, Rodney D , Cushing, Kelly C.

Mayo Clinic

Inflammatory Bowel Diseases | October 18, 2019 | Volume: 26 | Issue: 5 | Pages: 774-779

10.1093/ibd/izz209 | PMID 31626701 Get It

AbstractIntroductionUlcerative colitis (UC) associated with primary sclerosing cholangitis (PSC) is a rare phenotype. We aimed to assess patients with UC-PSC or UC alone and describe differences in clinical and phenotypic characteristics, antitumor necrosis factor (TNF) therapy, and long-term clinical outcomes.MethodsThis retrospective multicenter cohort study included patients who received a diagnosis of UC from 1962 through 2015. We evaluated clinical factors associated with UC-PSC vs UC alone and assessed associations by using multivariable logistic regression models.ResultsAmong 522 patients with UC, 56 (10.7%) had PSC. Compared with UC alone, patients with UC-PSC were younger (younger than 20 years) at diagnosis (odds ratios [OR], 2.35; adjusted P = 0.02) and had milder UC severity (adjusted P = 0.05), despite having pancolonic involvement (OR, 7.01; adjusted P < 0.001). In the biologics era (calendar year 2005 to 2015), patients with UC-PSC less commonly received anti-TNF therapy compared with patients with UC (OR, 0.38; adjusted P = 0.009), but their response rates were similar. Fewer patients with UC-PSC received corticosteroids (OR, 0.24; adjusted P = 0.005) or rectal 5-aminosalicyte acid (OR, 0.26; adjusted P < 0.001). Other differences were identified that were not statistically significant in a multivariable model: patients with UC-PSC more commonly were male, had lower rates of smoking, and had higher rates of colorectal cancer and colectomy.DiscussionThis study identified a unique phenotype of UC with concurrent PSC, which had different clinical behavior compared with UC only. These phenotypic characteristics can help identify high-risk patients with UC before PSC is diagnosed and guide different management and monitoring strategies.
Risk of Infections and Cancer in Patients With Rheumatologic Diseases Receiving Interleukin Inhibitors
Bilal, Jawad , Berlinberg, Adam , Riaz, Irbaz Bin , Faridi, Warda, Bhattacharjee, Sandipan , Ortega, Gilbert , Murad, M. Hassan , Alhifany, Abdullah A. , Murad, Mohammad H, Murad, M Hassan , Riaz, Irbaz B , Wang, Zhen , Prokop, Larry J. , Kwoh, Chian Kent

Mayo Clinic

JAMA Network Open | October 18, 2019 | Volume: 2 | Issue: 10 | Pages: e1913102

10.1001/jamanetworkopen.2019.13102 | PMID 31626313 Get It

Analysis of Temporal Trends and Variation in the Use of Defibrillation Testing in Contemporary Practice
Borne, Ryan T. , Randolph, Tiffany C., Wang, Yongfei , Curtis, Jeptha P. , Peterson, Pamela N., Masoudi, Frederick A. , Sandhu, Amneet , Zipse, Matthew M. , Thomas, Kevin L. , Kutyifa, V., Cha, Yong‐Mei , Hsu, Jonathan C. , Russo, Andrea M. , Hsu, Jonathan C , Peterson, Pamela N. , Desai, Nihar R.

Mayo Clinic

JAMA Network Open | October 18, 2019 | Volume: 2 | Issue: 10 | Pages: e1913553

10.1001/jamanetworkopen.2019.13553 | PMID 31626314 Get It

Developing a scalable FHIR-based clinical data normalization pipeline for standardizing and integrating unstructured and structured electronic health record data
Hong, Na , Shen, Feichen , Sohn, Sunghwan , Jiang, Guoqian , Wen, Andrew , Wang, Chen , Liu, Hongfang

Mayo Clinic

JAMIA Open | October 18, 2019 | Volume: 2 | Issue: 4 | Pages: 570-579

10.1093/jamiaopen/ooz056 | PMID 32025655 Get It

Abstract Objective To design, develop, and evaluate a scalable clinical data normalization pipeline for standardizing unstructured electronic health record (EHR) data leveraging the HL7 Fast Healthcare Interoperability Resources (FHIR) specification. Methods We established an FHIR-based clinical data normalization pipeline known as NLP2FHIR that mainly comprises: (1) a module for a core natural language processing (NLP) engine with an FHIR-based type system; (2) a module for integrating structured data; and (3) a module for content normalization. We evaluated the FHIR modeling capability focusing on core clinical resources such as Condition, Procedure, MedicationStatement (including Medication), and FamilyMemberHistory using Mayo Clinic’s unstructured EHR data. We constructed a gold standard reusing annotation corpora from previous NLP projects. Results A total of 30 mapping rules, 62 normalization rules, and 11 NLP-specific FHIR extensions were created and implemented in the NLP2FHIR pipeline. The elements that need to integrate structured data from each clinical resource were identified. The performance of unstructured data modeling achieved F scores ranging from 0.69 to 0.99 for various FHIR element representations (0.69–0.99 for Condition; 0.75–0.84 for Procedure; 0.71–0.99 for MedicationStatement; and 0.75–0.95 for FamilyMemberHistory). Conclusion We demonstrated that the NLP2FHIR pipeline is feasible for modeling unstructured EHR data and integrating structured elements into the model. The outcomes of this work provide standards-based tools of clinical data normalization that is indispensable for enabling portable EHR-driven phenotyping and large-scale data analytics, as well as useful insights for future developments of the FHIR specifications with regard to handling unstructured clinical data.
O5‐02‐04: INTEGRATIVE GENOMIC PROFILING TO IDENTIFY GENES AND PATHWAYS ASSOCIATED WITH VASCULAR RISK IN AD
Allen, Mariet , Reddy, Joseph S. , Carrasquillo, Minerva M. , Wang, Xue , Lincoln, Sarah, Nguyen, Thuy , Malphrus, Kimberly G., Asmann, Yan W. , Ertekin‐Taner, Nilüfer , Carrasquillo, Minerva M. , Murray, Melissa E. , Bu, Guojun , Dickson, Dennis W.

Mayo Clinic

Alzheimer's & Dementia | October 18, 2019 | Volume: 15 | Issue: 7S_Part_31 | Pages: No page available

10.1016/j.jalz.2019.06.4843 Get It

O4‐10‐01: CHARACTERIZING CELL TYPE‐SPECIFIC EXPRESSION SIGNATURES IN BRAIN USING SINGLE CELL RNA SEQUENCING
Carnwath, Troy , Lewis‐Tuffin, Laura J. , Allen, Mariet , Lincoln, Sarah, Wang, Xue , Deniz, Kaancan , İş, Özkan , Martin, Elizabeth, Louie, Christopher, Durán, Iván Segura, Wharen, Robert E. , Chaichana, Kaisorn L. , Quiñones‐Hinojosa, Alfredo , Ertekin‐Taner, Nilüfer , Patel, Tulsi , Garcia, César A. , ReFaey, Karim , Guerrero‐Cazares, Hugo

Mayo Clinic

Alzheimer's & Dementia | October 18, 2019 | Volume: 15 | Issue: 7S_Part_24 | Pages: No page available

10.1016/j.jalz.2019.06.4794 Get It

O2‐10‐01: STOP‐GAIN AND NON‐SYNONYMOUS VARIANTS IN NOVEL GENES OF AN IMMUNE CO‐REGULATORY NETWORK SHOW STRONG ASSOCIATION WITH ALZHEIMER'S DISEASE
Reddy, Joseph S. , Allen, Mariet , Wang, Xue , Gregory, Jenkins D., Carrasquillo, Minerva M. , Ertekin‐Taner, Nilüfer , Younkin, Steven G. , Biernacka, Joanna M. , Carrasquillo, Minerva M.

Mayo Clinic

Alzheimer's & Dementia | October 18, 2019 | Volume: 15 | Issue: 7S_Part_11 | Pages: No page available

10.1016/j.jalz.2019.06.4505 Get It

O2‐05‐04: PLASMA PTAU181 LEVELS REFLECT [18F]AV1451 TAU PET UPTAKE ACROSS THE TAUOPATHY SPECTRUM
Thijssen, Elisabeth H. , Airey, David , Proctor, Nicholas K. , Chai, Xiyun, Sims, John R. , Bourakova, Viktoriya, Strom, Amelia , Karydas, Anna M., Wang, Ping , Heuer, Hilary W. , Kramer, Joel H. , Rosen, Howard J. , Jagust, William J. , Boxer, Adam L. , Rojas, Julio C. , Joie, Renaud La , Dage, Jeffrey L. , Airey, David C., Miller, Bruce L. , Boeve, Bradley F. , Rabinovici, Gil D.

Mayo Clinic

Alzheimer's & Dementia | October 18, 2019 | Volume: 15 | Issue: 7S_Part_10 | Pages: No page available

10.1016/j.jalz.2019.06.4478 Get It

IC‐P‐189: REGIONAL AND VOXEL‐WISE SPATIAL RELATIONSHIPS AMONG FLUORINE‐18 AMYLOID PET TRACERS AND PITTSBURGH COMPOUND B
Adedokun, Adedamola, Marple, Laura M., Chen, Gengsheng , Hornbeck, Russ C. , Soucy, Jean‐Paul , Noto, Richard B., Jiménez‐Velázquez, Ivonne Z. , Gauthier, Serge , Surti, Ghulam M., Farlow, Martin R. , Salloway, Stephen , Flores, Shaney , Su, Yi , Gordon, Brian A. , Wang, Qing , Jack, Clifford R. , Roberson, Erik D. , Brooks, William S. , Hsiung, Ging‐Yuek Robin , McDade, Eric , Bateman, Randall J. , Benzinger, Tammie L.S.

Mayo Clinic

Alzheimer's & Dementia | October 18, 2019 | Volume: 15 | Issue: 7S_Part_3 | Pages: No page available

10.1016/j.jalz.2019.06.4304 Get It